Pharmaceutical company AbbVie Inc has asked a federal judge
to dismiss a lawsuit over its testosterone replacement drug
AndroGel, saying the plaintiff withheld information about his
alleged injuries until after discovery was completed.
In a motion filed on Monday before U.S. District Judge
Matthew Kennelly in Chicago, AbbVie said Froylan Garcia's
lawsuit should be thrown out because his lawyer failed to find
an expert witness to support his theory that AndroGel caused a
2013 blood clot.
To read the full story on Westlaw Practitioner Insights,
click here: bit.ly/2gb9DsF